IOVANCE BIOTHERAPEUTICS INC's ticker is and the CUSIP is 462260950. A total of 4 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,289,195 | +622.1% | 722,900 | +1017.3% | 0.00% | – |
| Q2 2023 | $455,488 | +79.6% | 64,700 | +55.9% | 0.00% | – |
| Q1 2023 | $253,565 | +35.9% | 41,500 | +42.1% | 0.00% | – |
| Q4 2022 | $186,588 | -61.6% | 29,200 | -42.4% | 0.00% | – |
| Q3 2022 | $486,000 | -92.3% | 50,700 | -91.1% | 0.00% | -100.0% |
| Q2 2022 | $6,305,000 | – | 571,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 216,600 | $1,384,074 | 0.00% |
| JANE STREET GROUP, LLC | 29,200 | $186,588 | 0.00% |
| SIMPLEX TRADING, LLC | 30,900 | $197 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |